Deutsche Bank AG Acquires Shares of 38,324 Ingevity Corporation $NGVT

Deutsche Bank AG bought a new position in shares of Ingevity Corporation (NYSE:NGVT) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor bought 38,324 shares of the company’s stock, valued at approximately $2,862,000.

A number of other large investors have also modified their holdings of the business. AQR Capital Management LLC lifted its stake in shares of Ingevity by 10.9% in the first quarter. AQR Capital Management LLC now owns 13,410 shares of the company’s stock worth $518,000 after buying an additional 1,323 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Ingevity by 5.2% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,790 shares of the company’s stock valued at $863,000 after acquiring an additional 1,080 shares in the last quarter. Empowered Funds LLC raised its holdings in Ingevity by 12.9% in the 1st quarter. Empowered Funds LLC now owns 5,181 shares of the company’s stock valued at $205,000 after acquiring an additional 594 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Ingevity by 311.8% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock worth $23,769,000 after purchasing an additional 454,579 shares in the last quarter. Finally, Jane Street Group LLC lifted its stake in Ingevity by 306.1% in the 1st quarter. Jane Street Group LLC now owns 88,883 shares of the company’s stock worth $3,519,000 after purchasing an additional 66,995 shares in the last quarter. Hedge funds and other institutional investors own 91.59% of the company’s stock.

Ingevity Price Performance

Shares of NGVT opened at $69.57 on Thursday. The firm has a 50-day simple moving average of $73.68 and a two-hundred day simple moving average of $71.83. The stock has a market cap of $2.39 billion, a PE ratio of 47.33 and a beta of 1.16. Ingevity Corporation has a 1-year low of $45.85 and a 1-year high of $79.29. The company has a debt-to-equity ratio of 22.52, a current ratio of 1.61 and a quick ratio of 1.15.

Ingevity (NYSE:NGVT) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $1.74 earnings per share for the quarter, topping analysts’ consensus estimates of $1.33 by $0.41. Ingevity had a net margin of 4.65% and a return on equity of 284.70%. The firm had revenue of $314.10 million during the quarter, compared to analysts’ expectations of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. As a group, analysts forecast that Ingevity Corporation will post 5.4 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on NGVT shares. Wall Street Zen lowered Ingevity from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 1st. Weiss Ratings raised Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Friday, July 31st. Two analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, Ingevity has an average rating of “Hold” and a consensus price target of $80.00.

Insider Buying and Selling at Ingevity

In related news, SVP Ryan C. Fisher sold 2,709 shares of the business’s stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $73.72, for a total value of $199,707.48. Following the sale, the senior vice president owned 15,722 shares in the company, valued at approximately $1,159,025.84. The trade was a 14.70% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO David H. Li sold 5,000 shares of the stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $75.83, for a total value of $379,150.00. Following the transaction, the chief executive officer directly owned 120,636 shares in the company, valued at approximately $9,147,827.88. The trade was a 3.98% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 17,801 shares of company stock valued at $1,347,481. Company insiders own 0.88% of the company’s stock.

Ingevity Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.